Gene therapy restores hearing in patients with rare genetic deafness, with dfnb9 trial results showing long-term benefits up to 2.5 years.
Anemia in older adults tied to higher dementia risk, with blood biomarkers linked to Alzheimer’s disease signaling neurodegeneration.
Risk stratification strategies help managing high-risk cancer screening in patients through validated tools and matching screening modality.
Covid-19 BA.3.2 Cicada variant shows 50+ spike protein mutations but remains low spread, offering insight into evolving Covid-19 dynamics
Blood test predicts alzheimer’s years early using plasma phosphorylated tau 217, with breakthrough findings from Mass General Brigham.
Advances in basal cell carcinoma improve care for common skin cancer by tailoring treatment to tumour characteristics and patient needs.